However, the AUC of ALT decreased with increasing severity of NAFLD, from 0.717 (95% CI, 0.624–0.810; P < .001) at US-FLI ≥ 5 points to 0.689 (95% CI, 0.558–0.689; P < .05) at US-FLI ≥ 6 points. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.